Haemonetics' GAAP loss for 3M 2022 fiscal year was $4.454 million, compared to a profit of $10.527 million in the previous year. Revenue increased 16.8% to $228.528 million from $195.577 million a year earlier.
Haemonetics' GAAP loss for 3M 2022 fiscal year was $4.454 million, compared to a profit of $10.527 million in the previous year. Revenue increased 16.8% to $228.528 million from $195.577 million a year earlier. 
English (US) 